News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fosun Pharma Given OK for Hong Kong IPO



4/12/2012 6:29:14 AM

April 11, 2012 --Shanghai Fosun Pharma has been given regulatory approval to issue 547 million H shares in a Hong Kong IPO. The transaction is expected to occur in the second quarter. Because the company's Shanghai stock price has slipped lower in the last six months, the offering has also dropped in size from the original announcement: it is now expected in a range between $600 million and $800 million, down from an initial $960 million. More details....

Stock Symbol: (SHA: 600196)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES